Invention Publication
- Patent Title: THERAPEUTIC OLIGONUCLEOTIDES
-
Application No.: US18531328Application Date: 2023-12-06
-
Publication No.: US20240247273A1Publication Date: 2024-07-25
- Inventor: Heather O'Neill , Mark Miglarese , David Spetzler
- Applicant: Caris Science, Inc.
- Applicant Address: US TX Irving
- Assignee: Caris Science, Inc.
- Current Assignee: Caris Science, Inc.
- Current Assignee Address: US TX Irving
- Main IPC: C12N15/115
- IPC: C12N15/115 ; A61K31/711 ; A61K47/68 ; G01N33/53
Abstract:
Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a therapeutic target such as Complement Component 1, Q Subcomponent (C1q) or a subunit thereof.
Information query
IPC分类:
